Clinical Studies on Emergo Therapeutics Lead Molecule for Acute Inflammatory Conditions

NCBiotech Grants & Loans

See the full listing of all NCBiotech grants and loans awarded since July 2012.

Organization
Emergo Therapeutics, Inc.
Award Date
Award Amount
500,000
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Moise Khayrallah
Fiscal Year
2020
Region
Research Triangle
Project Description: Emergo Therapeutics is developing a novel therapy aimed at disrupting the mast cells’ ability to release inflammatory cytokines and therefore reduce the impact of influenza symptoms. Emergo will use the SGL funds to complete their Phase II-B clinical study.
scroll back to top of page